The nuclear receptor Rev-erb-a modulates hepatic lipid and glucose metabolism, adipogenesis and the inflammatory response in macrophages. We show here that Rev-erb-a is highly expressed in oxidative skeletal muscle and that its deficiency in muscle leads to reduced mitochondrial content and oxidative function, as well as upregulation of autophagy. These cellular effects resulted in both impaired mitochondrial biogenesis and increased clearance of this organelle, leading to compromised exercise capacity. On a molecular level, Rev-erb-a deficiency resulted in deactivation of the Lkb1-Ampk-Sirt1-Ppargc-1a signaling pathway. These effects were recapitulated in isolated fibers and in muscle cells after knockdown of the gene encoding Rev-erb-a, Nr1d1. In complementary experiments, Rev-erb-a overexpression in vitro increased the number of mitochondria and improved respiratory capacity, whereas muscle overexpression or pharmacological activation of Rev-erb-a in vivo increased exercise capacity. This study identifies Rev-erb-a as a pharmacological target that improves muscle oxidative function by modulating gene networks controlling mitochondrial number and function.
Skeletal muscle contractility is important for locomotion and posture, activities performed by different myofiber types with distinct contractile and metabolic properties. Mitochondria serve a crucial function in the maintenance of skeletal myofiber homeostasis and matching energy production with demand. They do so through oxidation of glucose-derived pyruvate and β-oxidation of fatty acids, generating an electrochemical proton gradient through the respiratory complexes of the electron transport chain; this gradient can be used to drive the phosphorylation of ADP to ATP, a reaction called oxidative phosphorylation (OXPHOS). However, what determines mitochondrial content and function is not completely understood.
Nuclear receptors and their cofactors regulate metabolism in response to environmental signals and trigger homeostatic responses by coordinately regulating transcriptional networks. Previous studies have established that nuclear receptors, such as peroxisome proliferator-activated receptor-β/δ (Ppar-β/δ), estrogen-related receptor-α and estrogen-related receptor-γ, along with co-regulators such as Ppar-γ coactivator-1α (Ppargc-1α) and Ppargc-1β, as well as nuclear receptor co-repressor 1 (Ncor1), among others, control muscle physiology by modulating mitochondrial biogenesis and function, fiber type determination and switching and muscle vascularization [1] [2] [3] [4] [5] . Ppargc-1α is a master driver of mitochondrial biogenesis, and its overexpression in skeletal muscle results in increased mitochondrial number and function 1 , whereas skeletal muscle Ppargc-1α deficiency leads to a reduced number of mitochondria and a marked reduction of muscle oxidative capacity 6, 7 .
The nuclear receptor Rev-erb-α is expressed in tissues such as liver and adipose tissue 8 , where it modulates lipid, bile acid and glucose metabolism [8] [9] [10] [11] [12] [13] . In addition, Rev-erb-α controls adipogenesis 14, 15 and the macrophage inflammatory response 16 . Rev-erb-α interacts with Ncor1 and chromatin modifiers, such as histone deacetylase 3, to form a complex repressing target gene transcription 17 . Notably, a Rev-erb-α-Ppargc-1α cross-talk pathway regulates heme synthesis in hepatic cells 18, 19 . Whether Rev-erb-α interacts with Ppargc-1α in muscle and whether Rev-erb-α controls skeletal muscle oxidative capacity has not yet been investigated. Here we find through loss-and gain-of-function experiments, including pharmacological activation, that Rev-erb-α plays a key role in regulating the oxidative capacity of the muscle and exercise endurance, and thus it emerges as a potential target to improve muscle function.
RESULTS

Nr1d1 −/− mice have lower exercise capacity
Rev-erb-α expression is markedly higher in oxidative compared to more glycolytic muscles ( Fig. 1a) . Notably, its expression is higher in soleus and gastrocnemius muscle upon exercise training ( Supplementary  Fig. 1a ). Thus, we explored whether Rev-erb-α has a role in skeletal muscle oxidative capacity and exercise capacity. Nr1d1 −/− mice showed significantly less spontaneous locomotor activity in a free-wheel exercise regimen compared to wild-type (WT) littermates (Fig. 1b) .
We next assessed basal (VO 2b ) and maximal (VO 2max ) oxygen consumption, which reflect aerobic capacity, by submitting Nr1d1 −/− and WT mice to a forced progressive treadmill exercise. VO 2b measured at rest was not significantly different between the two genotypes, whereas VO 2max measured at exhaustion was significantly lower in Nr1d1 −/− mice (Fig. 1c) , resulting in a >60% reduction in aerobic capacity during exercise. In a standard endurance exercise test performed at 70% of their respective VO 2max , 50% of Nr1d1 −/− mice, compared to only 20% of the WT mice, stopped running within 50 min, which indicates their inability to sustain a long-lasting exercise ( Fig. 1d) . In this setting, Nr1d1 −/− mice ran for a significantly shorter time and distance than their WT littermates ( Fig. 1e,f) .
Rev-erb-a controls muscle mitochondrial content and function
We assessed the role of Rev-erb-α in the control of mitochondrial number and function in vivo (Fig. 2) . Mitochondrial DNA content was ~40% lower in skeletal muscle from Nr1d1 −/− mice compared to WT littermates ( Fig. 2a ), suggesting that Rev-erb-α is involved in regulating skeletal muscle mitochondrial content. Accordingly, expression of genes encoding subunits of the mitochondrial electron transport respiratory chain, such as NADH dehydrogenase 1, a subunit of complex I, and cytochrome c oxidase 1 and cytochrome c oxidase 2, two subunits of complex IV, was lower in soleus and phosphorylation, as illustrated by higher-state 3u respiration rate and respiratory control ratio (RCR, OXPHOS/leak), whereas the uncoupling proton leakage remained unchanged ( Fig. 3c) . Conversely, Nr1d1 silencing resulted in lower mitochondrial respiration compared to control shRNA-infected cells ( Supplementary Fig. 2a ), as well as the quantity of total (MitoTracker Green) and functional (MitoTracker Red) mitochondria ( Supplementary Fig. 2b ) in differentiated C2C12 cells. Analysis of mitochondrial fatty acid oxidation in permeabilized fibers of muscle from Nr1d1 −/− mice revealed compromised oxygen consumption in the presence of palmitoyl-l-carnitine plus malate alone and in the presence of ADP ( Fig. 2f) . In parallel, the expression of genes encoding enzymes of fatty acid β-oxidation, notably carnitine palmitoyltransferase 1B (Cpt1b) and (very) long chain (Acadvl and Acadl) and short chain (Acads) acyl-CoA dehydrogenases, was lower in skeletal muscle from Nr1d1 −/− compared with WT mice ( Fig. 2g and Supplementary Fig. 3a) , whereas REV-ERB-α retrovirus-infected C2C12 cells had a mirror phenotype (that is, higher Acadvl, Acadl and Acads expression, and thus a higher acyl-CoA dehydrogenase expression) compared to control cells infected with an empty control pBabe retrovirus ( Fig. 3d) . These results indicate that Rev-erb-α modulates fatty acid β-oxidation-driven generation of reducing equivalents to feed into the electron transport chain in vitro and ex vivo in skeletal muscle. Together, these results demonstrate that Rev-erb-α regulates muscle cell mitochondrial content and function. Electron microscopy analysis of muscle sections revealed a slight misalignment of Z lines, the presence of vacuolated fibers and the presence of abnormal, swollen and less dense mitochondria in muscle sections from Nr1d1 −/− mice compared to WT littermates ( Fig. 2h and Supplementary Fig. 4) , which indicate a severe skeletal muscle phenotype and mitochondrial dysfunction in the Nr1d1 −/− mice. The repair process, assessed by the presence of centrocellular nuclei ( Supplementary Fig. 5a shows that the nuclei are localized at the periphery of the fibers, confirming the absence of regeneration) and the absence of change in the expression of Pax7 and Myf5 ( Supplementary Fig. 5b) , was not different between Nr1d1 −/− mice and WT littermates. In line with this, immunofluorescence staining of Pax7 indicated its localization at the boundary of the myofiber (Supplementary Fig. 5c ), which implies the presence of quiescent quadriceps muscle from Nr1d1 −/− mice compared to WT mice ( Fig. 2b and Supplementary Fig. 1b ). In addition, relative protein amounts of the mitochondrial oxidative phosphorylation complexes were lower in muscle from Nr1d1 −/− mice compared to WT mice ( Fig. 2c and Supplementary Fig. 1c ). Moreover, glutamate-malate-stimulated (state 2) respiration was lower in isolated fibers from Nr1d1 −/− mice compared to WT mice, in line with the reduced mitochondrial content ( Fig. 2d) . Mitochondrial oxidative capacity was impaired in muscle from Nr1d1 −/− mice, as attested by a significantly lower ADP-driven glutamate-malate (state 3) respiration rate in saponinpermeabilized fibers isolated from Nr1d1 −/− compared to WT mice (Fig. 2d) . The lower respiration upon addition of succinate and rotenone demonstrates a reduced capacity of the entire chain rather than a deficiency in a specific complex. This was further underscored by the significantly lower respiration rate observed when comparing equal amounts of isolated mitochondria ( Fig. 2e) , illustrating not only less mitochondrial content but also lower respiratory chain function of isolated mitochondria from Nr1d1 −/− compared to WT mice. Although gene expression analysis of fiber type markers suggested a switch toward a more glycolytic profile (expression of the genes encoding tropomyosin 3, a marker of oxidative type I fiber, and myosin heavy chain IIa and IIx, markers of mostly oxidative fibers, is lower in soleus and quadriceps muscle from Nr1d1 −/− mice compared to WT mice (data not shown)), specific type I, type IIa and type IIb immunostaining did not reveal any significant changes between the two genotypes ( Supplementary Fig. 1d ). In addition, expression of Mb (the gene encoding myoglobin) and vascularization, assessed by CD31 immunostaining on soleus muscle sections, was similar between the two genotypes ( Supplementary Fig. 5d ,e).
To study whether Rev-erb-α regulates mitochondrial function in a cell-autonomous manner, we stably infected C2C12 muscle cells with a REV-ERB-α-coding retrovirus. Staining with MitoTracker Green, a marker of mitochondria content, was higher in cells overexpressing REV-ERB-α compared with those infected with a control vector ( Fig. 3a) . Notably, the red-to-green ratio of JC-1 fluorochrome, an indicator of membrane potential, was also higher in C2C12 cells overexpressing REV-ERB-α compared to cells infected with an empty pBabe control retrovirus, suggesting increased mitochondrial activity (Fig. 3b) . REV-ERB-α expression enhanced the maximal respiratory capacity through enhanced coupled ATP-producing oxidative npg satellite cells located on the border of myofibers, which are similar in the two genotypes.
Rev-erb-a increases skeletal muscle mitochondrial biogenesis
We assessed whether Rev-erb-α regulates mitochondrial biogenesis in loss-and gain-of-function settings ( Fig. 4) . Both mRNA (~56%) and protein (~50%) amounts of Ppargc-1α, which has a pivotal role in mitochondrial biogenesis, were lower in soleus and quadriceps muscle from Nr1d1 −/− mice as compared to WT mice ( Fig. 4a and Supplementary Fig. 3b,d) . Consistently, the expression of Tfam and Nrf1, encoding mitochondrial transcription factor A and nuclear respiratory factor 1, respectively, two transcription factors that are involved in mitochondrial biogenesis, was lower in Nr1d1 −/− mice compared to WT mice ( Fig. 4b) . By contrast, REV-ERB-α overexpression resulted in higher Ppargc1a and Tfam expression in C2C12 cells compared to cells infected with an empty pBabe control retrovirus ( Fig. 4h) .
As a functional reflection of impaired mitochondrial electron transport chain activity, ATP concentrations were significantly lower in muscle from Nr1d1 −/− mice compared to WT mice ( Fig. 4c) . Ampk, a 'fuel gauge' activated by liver kinase B1 (Lkb1, also known as serinethreonine kinase 11 or Stk11) when the AMP/ATP ratio increases, induces Sirt1-dependent deacetylation of Ppargc-1α and expression of nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme in the synthesis of the Sirt1 cofactor NAD + , thus affecting mitochondrial and lipid oxidation genes 20 . Of note, Stk11 gene expression ( Fig. 4d and Supplementary Fig. 3d ), Ampk phosphorylation ( Fig. 4e) and activity illustrated by the p-Acac/Acac (phosphorylated acetyl-CoA carboxylase/total acetyl-CoA carboxylase) ratio ( Supplementary  Fig. 3c ) and Nampt gene expression ( Fig. 4f) were lower in muscle from Nr1d1 −/− mice compared to WT mice. Concentrations of NAD + and NADH, the reducing equivalent produced by fatty acid oxidation, were lower in skeletal muscle from Nr1d1 −/− mice compared to that of their WT littermates ( Fig. 4f) . Moreover, we observed significantly less Sirt1 expression in skeletal muscle from Nr1d1 −/− compared to WT mice ( Fig. 4f and Supplementary Fig. 3d ), and SIRT1 activity was blunted, as attested by increased Ppargc-1α acetylation (Fig. 4g) . Conversely, Sirt1 and Nampt expression was induced in REV-ERB-α-overexpressing C2C12 cells ( Fig. 4h) and accompanied by significantly improved mitochondrial respiration, an effect that was fully blocked by the addition of the C compound, an inhibitor of Ampk phosphorylation ( Fig. 4i) . Consistent with this, siRNA knockdown of genes encoding Ampk (Prkaa1 and Prkaa2) prevented the increase in mitochondrial content upon REV-ERB-α overexpression ( Fig. 4j) , whereas Ampk activation by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) increased mitochondrial number in cells stably transduced with Nr1d1 shRNA but not to the same extent as in control cells stably transduced with control shRNA ( Supplementary  Fig. 2c ). Together, these data indicate that Rev-erb-α regulates skeletal muscle mitochondria biogenesis through modulation of the Lkb1-Ampk-Sirt1-Ppargc-1α pathway.
Rev-erb-a deficiency induces skeletal muscle autophagy
We next explored whether Rev-erb-α also modulates mitochondrial degradation. Autophagy is a process mediating the selective clearance of cytoplasmic components, such as damaged mitochondria, that could otherwise become deleterious. Autophagy is a self-digestion process occurring through the formation of a vesicle (nucleation) that expands to become an autophagosome, which then engulfs cellular components and directs them to the lysosome for degradation. Expression of the genes encoding Ulk1, a protein of the initiation complex implicated in vesicle formation, and Beclin1, a protein of 0.6
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WT Nr1d1 npg the nucleation complex, as well as autophagy-related 5 (Atg5) and Bnip3, which are responsible for vesicle elongation and autophagosome formation, and the lysosomal enzymes cathepsin L (Ctsl) and ATPase6v1b2 was higher in skeletal muscle of Nr1d1 −/− compared to WT mice (Fig. 5a,b) and lower in REV-ERB-α retrovirus-infected C2C12 cells compared to control cells infected with an empty pBabe control retrovirus (Supplementary Fig. 6 ). Rev-erb-α also regulated gene and protein expression of Parkin (also known as Park2), a protein specifically involved in mitochondrial clearance 21 ( Fig. 5b and Supplementary Fig. 6 ). The functional increase of autophagy was illustrated by the maturation of microtubule-associated protein 1 light chain 3α (Map1lc3a-I, also known as LC3) to its lipidated form, Map1lc3a-II, a marker of ongoing autophagy associated with the autophagosome membrane ( Fig. 5c) . Moreover, treatment with the lysosome inhibitors bafilomycin and NH 4 Cl, which block the fusion of the lysosome with mature autophagosomes that subsequently accumulate, resulted in a smaller increase of Map1lc3a-II expression in REV-ERB-α-overexpressing C2C12 cells than in treated control (pBabe) cells (Fig. 5d ). This indicates that autophagy flux is lower when REV-ERB-α is overexpressed. Conversely, the number of mitochondria was lower after Nr1d1 silencing in C2C12 cells, and addition of the autophagy blockers 3-methyl adenine and chloroquine or the lysosome inhibitors bafilomycin and NH 4 Cl prevented this decrease (Fig. 5e) . These results suggest that Rev-erb-α deficiency results in an increased autophagy flux, thus contributing to the lower mitochondria number.
To gain further mechanistic insight, we examined the distribution of Rev-erb-α binding sites in the vicinity of autophagy genes, assessed using chromatin immunoprecipitation (ChIP) sequencing data 17 , and overlaid it with epigenetic marks obtained in C2C12 myotubes 22 . We reasoned that intense transcriptional activity at these marks may increase the likelihood of Rev-erb-α binding to these locations. Primers for ChIP-quantitative PCR (qPCR) targeting these regions were then designed to assess REV-ERB-α binding and changes in acetylation marks in REV-ERB-α-expressing C2C12 cells. We observed an enrichment of Rev-erb-α binding in the regulatory regions of several autophagy genes (Fig. 5f) , which was associated with decreased acetylation at histone 3 Lys27 (H3K27) (Fig. 5g) and Lys9 (H3K9) (Fig. 5h) .
Rev-erb-a activation improves muscle mitochondrial function Next, we determined the effect of pharmacological activation of Rev-erb-α on exercise capacity, which we achieved by treating mice with the synthetic ligand SR9009 (ref. 12) . Notably, in an endurance exercise test, mice treated with SR9009 ran significantly longer, both in time and in distance, than mice treated with vehicle (Fig. 6a) .
Incubation of C2C12 cells with two different Rev-erb agonists, SR9009 and SR9011, increased the number of total (MitoTracker Green) and active (MitoTracker Red) mitochondria (Fig. 6b) . Finally, skeletal muscle-specific Rev-erb-α overexpression in mice significantly improved mitochondrial function, as attested by a significant increase in glutamate-malate-stimulated and ADP-driven respiration in the absence and presence of succinate in permeabilized fibers (Fig. 6c) . Together, these data indicate that enhancement of Rev-erb-α expression, activity or both exerts beneficial direct effects on skeletal muscle to improve mitochondrial respiration and exercise capacity.
DISCUSSION
Our results from both gain-and loss-of-function experiments identify Rev-erb-α as a physiological regulator of muscle mitochondrial content and oxidative function. This is supported by several observations. First, Rev-erb-α is preferentially expressed in more oxidative muscles, such as soleus muscle, and Nr1d1 −/− mice have notably altered exercise capacity associated with a marked decrease in mitochondrial content and function, the presence of swollen mitochondria and abundant vacuoles within the fibers. We observed similar alterations upon knockdown of Nr1d1 in differentiated C2C12 myotubes (lower mitochondrial content and impaired mitochondrial function). By contrast, pharmacological activation or skeletal muscle-specific Rev-erb-α overexpression in vivo and in vitro in C2C12 cells resulted in the opposite phenotype, highlighting the fact that Rev-erb-α exerts a direct action on skeletal muscle cells. Second, our data indicate that Rev-erb-α controls mitochondrial biogenesis and respiration through the Lkb1-Ampk-Sirt1-Ppargc-1α signaling pathway. Finally, we show that skeletal muscle Rev-erb-α regulates several genes involved in different steps of the autophagy process, including genes more specifically dedicated to mitophagy. Together, these data support the concept that Rev-erb-α acts through a two-pronged mechanism, involving both biogenesis of new mitochondria and clearance of defective mitochondria. Thus, when Rev-erb-α is activated, there is an increase in mitochondrial number and a better control of autophagic flux, allowing for a higher oxidative capacity. The regulation of the Lkb1-Ampk-Sirt1-Ppargc-1α pathway by Rev-erb-α provides a molecular mechanism whereby Rev-erb-α controls mitochondrial biogenesis and function. Ampk and Sirt1 are crucial in the metabolic flexibility that allows skeletal muscle to switch to lipid oxidation during fasting and exercise. Deficient Ampk activity in Nr1d1 −/− mice is associated with impaired Sirt1-mediated Ppargc-1α deacetylation and the ensuing attenuated induction of mitochondrial fatty acid oxidation gene expression and reduced exercise capacity 20, 23 . Likewise, Ppargc-1α acetylation is higher and its expression diminishes in Rev-erb-α deficiency, which may contribute to the reduced number of mitochondria, lower expression of transcription factors important for mitochondrial function, such as Tfam, and altered electron transport chain activity. In addition, expression of genes encoding fatty acid β-oxidation enzymes as well as palmitate-induced mitochondrial respiration is compromised in the absence of Rev-erb-α. A considerable deactivation of the Lkb1-Ampk-Sirt1-Ppargc-1α pathway when Rev-erb-α is deficient is further shown by defective Ampk activation, reduced NAD + concentrations and markedly altered Sirt1 and Nampt expression. Moreover, siRNAmediated or C compound-mediated inhibition of Ampk activity, which blocks the stimulatory effect of REV-ERB-α overexpression on mitochondrial respiration, demonstrates that Rev-erb-α-mediated improvement of mitochondrial respiration requires active Ampk. Of note, in Nr1d1 −/− mice, Ampk phosphorylation is not induced even though ATP concentrations are low. Binding of AMP increases the ability of other kinases to phosphorylate and activate the Ampk-α subunit. Lkb1, expressed in skeletal muscle, is a major upstream kinase that phosphorylates and activates Ampk, and Stk11-deficiency results in blunted Ampk activation, decreased Ppargc1a expression, reduced exercise capacity and compromised mitochondrial activity 24, 25 , a phenotype similar to the one observed in the Nr1d1 −/− mice. Our results also indicate that mitochondria are damaged and mitochondrial oxygen consumption is reduced in muscle from Nr1d1 −/− mice, whereas skeletal muscle-specific Rev-erb-α overexpression improves mitochondrial respiration. Moreover, treatment of mice with a synthetic Rev-erb-α agonist increases oxygen consumption 12 . Notably, and in contrast to other transcriptional regulators, such as Ppar-β/δ (ref.
2) and Ppargc-1α (refs. 1,6), Rev-erb-α modulates skeletal muscle oxidative capacity without inducing a fiber type switch, suggesting a disconnection between both phenomena upon Rev-erb-α deficiency. Together, these data support a prominent role for Rev-erb-α in skeletal muscle mitochondria function.
Autophagy is a dynamic self-digestion process that ensures the selective clearance of damaged organelles or aggregated macromolecules, which is a particularly important mechanism in differentiated cells such as myotubes [26] [27] [28] . Our data demonstrate that Rev-erb-α exerts a tight control on this pathway by regulating several genes involved in vesicle nucleation and expansion, autophagosome formation and lysosomal enzymatic activities. The conversion of Map1lc3a-I to its lipidated form, Map1lc3a-II, is a hallmark of autophagy 29 . The rate of maturation to Map1lc3a-II was elevated in the absence of Rev-erb-α, whereas autophagy flux is decreased by REV-ERBα overexpression. Of note, Rev-erb-α represses genes encoding proteins that trigger mitophagy, such as Park2, a cytosolic E3 ubiquitin ligase that translocates to depolarized mitochondria to induce mitophagy, thereby maintaining a pool of functioning mitochondria and limiting oxidative damage 21 . Likewise, Rev-erb-α downregulates Ulk1, which not only participates in the initiation complex but also may play an important part in triggering mitophagy 30 results in accumulation of defective mitochondria in mature red blood cells 31 . Finally, we demonstrate that autophagy blockade by autophagy or lysosome inhibitors reverses the effect of Nr1d1 knockdown on total mitochondria number. Autophagy is also a survival mechanism by which cells produce energy in times of nutrient paucity. One of the most potent inducers of autophagy is Ampk, which directly phosphorylates Ulk1 and, simultaneously, turns off signaling of mTORC1, an inhibitor of autophagy 26, 28, 32 . However, neither Ampk (which is downregulated in the absence of Rev-erb-α) nor mTOR, whose signaling is not regulated by Rev-erb-α (data not shown), is likely to mediate Rev-erb-α's action on autophagy. Another potent autophagy inducer, Sirt1 (ref. 33) , is also downregulated in the absence of Rev-erb-α, again excluding the possibility that Sirt1 has a role in the observed phenotype. Together, these data indicate that Rev-erb-α bypasses these regulators and represses autophagy genes directly, probably by binding the DNA in their regulatory regions. Indeed, our ChIP-qPCR data confirmed Rev-erb-α binding enrichment in the regulatory regions of autophagy genes. This was accompanied by a modification of epigenetic marks at these sites, as indicated by decreased H3K27 and H3K9 acetylation, which is consistent with the repressive role of Rev-erb-α on gene transcription.
Rev-erb-α is a component of the circadian clock, which allows synchronization of internal rhythms to daily environmental cues 34 . Skeletal muscle has circadian rhythmicity of gene expression 35, 36 , and the clock components Clock and Bmal1 (brain and muscle Arnt-like 1) have been shown to participate in the maintenance of skeletal muscle function 37 . The mRNA concentrations of the clock genes are altered in skeletal muscle from Nr1d1 −/− mice (Supplementary Fig. 7a) , and REV-ERB-α overexpression in synchronized C2C12 cells leads to an altered circadian expression pattern of Ppargc1a ( Supplementary  Fig. 7b ). Pharmacological activation of Rev-erb-α alters the circadian rhythms of Cpt1b and Ppargc1a in skeletal muscle 12 . Consequently, in addition to the direct action of Rev-erb-α on autophagy genes and mitochondrial biogenesis and function, Nr1d1 deletion or overexpression that causes disturbed circadian rhythmicity may contribute to the observed phenotype. In conclusion, Rev-erb-α is a major physiological regulator of mitochondrial content and oxidative function. Thus, pharmacological activation of Rev-erb-α may be a promising approach for the treatment of skeletal muscle diseases with compromised exercise capacity.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
Mice. We used Nr1d1 −/− mice 38 and their wild-type (WT) littermates (Nr1d1 +/+ mice). Mice were housed in a 12 h-12 h light-dark cycle and allowed ad libitum access to food and water. They received a regular chow diet. Mice were killed by cervical dislocation, and skeletal muscles were snap-frozen in liquid nitrogen and stored at −80 °C until RNA and protein isolation and histological staining. Rev-erb-α deficiency in mice was verified by qPCR analysis of skeletal muscle gene expression of Nr1d1and its known target gene Arntl, also known as Bmal1 (Supplementary Fig. 8a) .
For Rev-erb-α overexpression, we cloned the coding sequence of Rev-erb-α in front of a muscle creatine kinase (MCK) promoter, allowing muscle-specific expression, and introduced a 1/2 adeno-associated virus (AAV) vector (Sirion Biotech, Germany). We injected 2.1 × 10 10 infectious particles intramuscularly into the tibialis anterior muscle using the tibialis anterior muscle of the contralateral limb as control. For pharmacological activation, SR9009 was administered intraperitoneally at 100 mpk for 30 d as previously described 12 . Control mice were injected with vehicle (15% cremophor in sterile water).
Maximal exercise stress test and endurance capacity. Two days before the experiment, mice were acclimatized to a single lane treadmill by performing a 10 m min −1 run. The day of the exercise stress test, mice were placed into the treadmill enclosed in a metabolic chamber connected to an oxygen sensor (Oxymax, Columbus Instruments, Columbus, Ohio). We measured basal oxygen consumption (VO 2b ) after a 30-min resting period; then, mice were encouraged to run on the treadmill at 10 m min −1 and 0% incline. Every 3 min, the treadmill speed was incremented by 4 m min −1 until the mice reached exhaustion to determine their maximal VO 2 (VO 2max ). The speed at which VO 2max was obtained was considered the maximal running speed (V max ). One week later, we tested the mice for their endurance capacity. After a 6-min run at 30% of their maximal running speed, the treadmill speed was set at 70% of the VO 2max . The experiment was stopped when mice stayed for 5 s continuously on the electrical grid. Time to exhaustion and total running distance were determined.
Daily wheel running activity. To record daily running wheel behavior, we placed the mice into individual cages containing running wheels for 3 weeks (Campden, Phymep, Paris). Wheel revolution was recorded daily during the last 2 weeks and averaged.
Training. We examined Rev-erb-α expression in control (untrained) and exercised mice. Mice were trained for 8 weeks, 5 d per week, 1-2 h per day at a starting speed of 8 m min −1 , which was increased up to 16 m min −1 during the last 4 weeks.
Mouse care and use were performed according to approved institutional guidelines, and all experimental procedures were approved by the relevant ethic committees (Comité d' éthique en expérimentation animale Nord-Pas-De-Calais and The Scripps Research Institute Florida Campus Institutional Animal Care and Use Committee). We used male mice for all experiments.
Cell culture. We cultured C2C12 myoblasts in Dulbecco's modified Eagle's medium (DMEM; 4.5 g l −1 d-glucose; Gibco) supplemented with 10% FBS and 1% gentamycin. Myogenic differentiation into myotubes was induced when cells reached 80% confluency by adding DMEM supplemented with 2% horse serum and 1% gentamycin at 37 °C in a humidified incubator under 5% CO 2 for 2-5 d. As indicated in Figure 6 , we added SR9009 or SR9011 (5 µM) to the medium 1 d before differentiation and for the length of the differentiation period (8 d).
Serum shock. We assessed circadian gene expression patterns in cells after synchronization by a 2-h horse serum shock on near-confluent cells 39 . After 2 h, the medium was changed to 2% serum-containing medium as above.
Retroviral production and infection. We cultured Phoenix Eco cells (Orbigen) in DMEM containing 10% FBS and 1% gentamycin at 37 °C under standard culture conditions. To generate cell lines constitutively overexpressing REV-ERB-α, we inserted the coding sequence of human NR1D1 in the pBabe retrovirus plasmid (Addgene) using the BamHI-SalII sites to generate pBabe-REV-ERB-α. We used the empty vector (pBabe) as control. To downregulate Nr1d1 expression, we inserted the Nr1d1 shRNA sequence in psilencer 5.1-U6 Retro (Ambion) using the BamH1 and HindIII sites. Phoenix cells (100,000 per cm 2 ) were transfected with the pBabe plasmid constructs (20 µg) using the cationic lipid RPR 120535B as previously described 40 . C2C12 cells were infected with the supernatant from pBabe or pBabe-REV-ERB-α, and control (CTL) shRNA or Nr1d1 shRNA and puromycin-resistant infected cells were used within 15 d after infection. We verified NR1D1 overexpression by RT-qPCR on REV-ERB-α retrovirus-infected C2C12 cells compared to pBabe retrovirus-infected control cells (Supplementary Fig. 8b) . We verified REV-ERB-α nuclear localization by western blot analysis (Supplementary Fig. 8c) , and we verified its repressive transcriptional activity by transient transfection on a consensus RevDR2 site in C2C12 cells infected with REV-ERB-α retrovirus compared to those infected with pBabe retrovirus, as well as to noninfected C2C12 cells after transfection of a pSG5Rev-erb-α expression plasmid as control ( Supplementary  Fig. 8d ). Nr1d1 downregulation was verified by qPCR analysis of Nr1d1 mRNA on Nr1d1 shRNA-transduced C2C12 cells compared with control cells (Supplementary Fig. 8e ).
Determination of cellular respiration. C2C12 cells (1 × 10 6 cells ml −1 ) suspended in cell culture medium (RPMI + 10% FCS) were placed into the chambers of the O2K oxygraph operating at 37 °C. Routine respiration was measured 20 min later. Then, 2 µg ml −1 oligomycin was injected into the chambers to obtain the oligomycin-inhibited leak rate of respiration (4o, Leak, 'L'), or uncoupled respiration. Finally, pulses of carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) (1 µM) were added into the chambers until maximal oxygen consumption was reached (3u, OXPHOS, 'P'). It represents the maximal respiratory capacity. The respiratory control ratio (RCR), or the coupled oxidative phosphorylation, is expressed as 3u/4o ratio.
Oxygen consumption on permeabilized soleus fibers. After cervical dislocation, soleus or tibialis anterior muscles were excised and placed into a Petri dish containing ice-cold biopsy preservation solution (BIOPS), and permeabilized fibers were prepared as previously described 41 . We placed fibers (3-6 mg wet weight) into the O2K oxygraph chambers (Oroboros Instruments, Innsbruck, Austria). In the first chamber, we added glutamate (10 mM) and malate (2 mM) to obtain state 2 respiration. Then, we injected 2.5 mM ADP into the chamber to measure ADP-coupled oxygen consumption (state 3). Further addition of succinate (10 mM) allowed estimation of the entire OXPHOS capacity. Finally, complex I and complex III were inhibited with rotenone (0.5 µM) and antimycin A (2.5 µM), respectively. In the second chamber, we added palmitoyl-carnitine (5 or 20 µM) and malate (2 mM). After stabilization, coupled respiration was obtained with 2.5 mM ADP. Addition of exogenous cytochrome c (10 µM) was done in all experiments to test external membrane integrity. Experiments were performed at 25 °C.
Muscle mitochondria isolation. We cut muscles into small pieces and placed them into a trypsin-EDTA solution for 15 min at 4 °C. Samples were rinsed with mitochondrial isolation buffer (in mM: sucrose 300, TES 5, EGTA 0.2; pH 7.2) and homogenized with a glass tissue grinder. After centrifugation at 800 g for 7 min, supernatant was collected and spun twice at 8,800g. The final mitochondrial pellet was suspended into respiration medium Mitomed2 and mitochondria (150 µg) were placed into the oxygraph chambers. Substrates and protocols were as described for permeabilized fiber respiration.
Mitochondria quantity and function. Quantification of mtDNA copy number. We isolated mitochondrial DNA (mtDNA) from mouse muscles after digestion with Proteinase K (100 µg ml −1 ) by phenol/chloroform extraction. Relative amounts of nuclear DNA and mtDNA were determined by quantitative real-time PCR. We selected NADH dehydrogenase 1-coding gene for quantification of mtDNA and Ppia (also known as cyclophilin) for nuclear DNA quantification.
MitoTracker-FACS quantification. REV-ERB-α-overexpressing, Nr1d1 shRNA-transduced cells and their respective control cells were washed with PBS, trypsinized and incubated at 37 °C for 20 min with 100 nM MitoTracker Green FM and Red FM dyes (Molecular Probes). MitoTracker Green probe preferentially accumulates in mitochondria, allowing estimation of mitochondrial quantity. MitoTracker Red probe is a red fluorescent dye that stains mitochondria npg in living cells and its accumulation is dependent on the membrane potential (Molecular Probes). Samples were washed 3 times in PBS and subjected to flow cytometric analysis on a FACSCalibur apparatus (Becton Dickinson, San Jose, California). ATP assay. We measured ATP concentrations using a commercially available kit (EnzyLight ATP Assay Kit, Bioassay Systems, Hayward, California, USA) following the manufacturer's instructions. NAD assay. We measured NAD + and NADH concentrations using a commercially available kit (Biovision Research Products, Mountain View, California, USA) following the manufacturer's instructions.
Quantitative PCR. We isolated total RNA from tissues by guanidinium thiocyanate/phenol/chloroform extraction 42 and from C2C12 cells using the Trizol reagent (Invitrogen). Isolated RNA was reverse transcribed into cDNA using commercially available reagents (Superscript II kit, Applied Bioscience). We performed quantitative PCR (qPCR) with the Brilliant III SYBR Green QPCR Master Mix (Agilent) and specific primers following manufacturer's instructions and using a Mx3005 apparatus (Agilent). Gene expression was normalized to cyclophilin and expressed as indicated in the legends to figures. A list of specific primers is available in Supplementary Table 1 .
Antibodies and immunoblotting. Proteins extracted from muscle biopsies or cells were separated by SDS-PAGE and we performed immunoblot analyses according to standard procedures. Proteins were transferred onto PVDF membranes and immunoblot analyses were carried out using antibodies directed against p-AMPK (Thr172) (1:1,000, Cell Signaling Technology 2535) and AMPK (1:1,000, Cell Signaling Technology 2532), Ppargc-1α (1:500, Santa-Cruz Biotechnology, sc-13067), Gapdh (1:500, Santa-Cruz Biotechnology, sc-25778), actin (1:1,000, Santa-Cruz Biotechnology sc-1616), Bnip3 and Map1lc3a (1:1,000, Abcam38621 and Abcam51520, respectively), Park2 (1:1,000, Millipore ab9244), Acac (1:1,000, Cell Signaling 3662), p-Acac (S79) (1:1,000, Cell Signaling 3661), OXPHOS (1:1,000, MitoSciences InVitrogen, iv 458099), Rev-erb-α (1:1,000, Perseus Proteomix PP-A8740A-00) following the manufacturer's instructions.
Ppargc-1a acetylation assay. We analyzed Ppargc-1α acetylation in quadriceps muscle by immunoprecipitation of Ppargc1-α from 500 µg of protein extract with antibodies to Ppargc-1α (Santa Cruz, sc-13067, 2 µg per sample) followed by western blot analysis using antibodies to acetyl-lysine (1:2,000, Cell Signaling 9441).
Electron microscopy analysis of muscle sections. We examined ultrastructural muscle morphology using transmission electron microscopy. To this end, muscle tissue blocks were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Post-fixation was performed in 1% OsO 4 in 0.1 M cacodylate buffer (pH 7.4) supplemented with 1.5% K 4 [Fe(CN) 6 ]. Subsequently, samples were dehydrated and embedded in epon. Ultrathin sections were examined using a Philips CM100 electron microscope.
